Implications of New Multiple Sclerosis Criteria on Overlapping Autoimmune Conditions: Joseph Kuchling, MD

WATCH TIME: 4 minutes

"Hopefully, these new criteria will help us secure earlier diagnoses and treatments for these patients who are often caught between diagnoses."

Research has shown that some patients with anti-N-methyl-D-aspartate receptor encephalitis (NMDARE) exhibit clinical symptoms and T2-hyperintense MRI lesions resembling those seen with multiple sclerosis (MS). However, specific MRI characteristics of this overlap syndrome remain poorly understood. In a recent study conducted by lead author Joseph Kuchling, MD, and colleagues, findings confirmed that overlap with MS was common among patients with NMDARE. This suggests a potential pathophysiological link between the 2 conditions, highlighting the need for tailored diagnostic and therapeutic approaches to manage NMDARE and MS effectively.

Presented at the 2024 European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Congress, held September 18-20, in Copenhagen, Denmark, the study compared neuroimaging data from patients with overlapping NMDARE-MS and those with NMDARE alone, using data from the GErman NEtwork for Research of AuToimmune Encephalitis network. Key findings revealed that patients with the overlap syndrome exhibited atypical NMDARE symptoms, a conventional MRI lesion pattern typical of MS, rapid lesion progression, and MS-specific lesion features, such as the central vein sign, on 7T-MRI imaging.

At the Congress, Kuchling, a postdoctoral research assistant at Charité University Berlin, discussed these findings and their implications with NeurologyLive^®. During the conversation, Kuchling emphasized how the evolving diagnostic criteria could significantly impact the management of patients with overlapping autoimmune and neurological conditions. He highlighted the need for healthcare systems to address the challenges faced by patients in the diagnostic gray area. Additionally, Kuchling underscored the importance of further research to refine follow-up care protocols to detect and manage underlying neurological diseases in patients initially diagnosed with autoimmune encephalitis.

Click here for more coverage of ECTRIMS 2024.

REFERENCES
1. Kuchling J, Penner L, Fernandez Ceballos R, et al. NMDA Receptor Encephalitis and Multiple Sclerosis Overlap Syndrome - Part I: Clinical Findings and MRI Characteristics. Presented at ECTRIMS Congress; September 18-20, 2024; Copenhagen, Denmark. Scientific Session 1: New diagnostic criteria. Abstract 2310.